Use of muscle relaxants in nonspecific lower back pain


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The priority in the management of a patient with back pain is its earliest possible relief. It is important to involve the patient in a set of remedial and rehabilitation treatments and to prevent chronic pain syndrome. Factors, such as pain intensity and duration, concomitant diseases, and ongoing therapy tolerability, play a crucial role in the choice of therapy. Muscle relaxants can alleviate or even eliminate excessive muscle tension. Their co-administration with nonsteroidal anti-inflammatory drugs makes it possible to lower the dosage of the latter and the risk of side effects.

Full Text

Restricted Access

About the authors

O. Kotova

International Society «Stress under Control»

Email: ol_kotova@mail.ru
Candidate of Medical Sciences

A. Artemenko

I.M. Sechenov First Moscow State Medical University (Sechenov University)

E. Akarachkova

International Society «Stress under Control»

A. Belyaev

N.V. Sklifosovsky Research Institute of Emergency Care

References

  1. Kelsey J., White A. Epidemiology and impact of low back pain // Spine. -1980; 5 (2): 133-9. doi: 10.1097/00007632-198003000-00007.
  2. Vos T., Flaxman A., Naghavi M. et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 // Lancet. - 2012; 380 (9859): 2163-96.
  3. Hoy D., Bain C., Williams G. et al. A systematic review of the global prevalence of low back pain // Arthritis Rheum. - 2012; 64 (6): 2028-37.
  4. Machado G., Maher C., Ferreira P. et al. Can Recurrence After an Acute Episode of Low Back Pain Be Predicted? // Phys. Ther. - 2017; 97 (9): 889-95. doi: 10.1093/ptj/pzx067.
  5. Hoy D., Brooks P., Blyth F. et al. The Epidemiology of low back pain // Best Pract. Res. Clin. Rheumatol. - 2010; 24 (6): 769-81. doi: 10.1016/j.berh.2010.10.002.
  6. Wertli M., Rasmussen-Barr E., Weiser S. et al. The role of fear avoidance beliefs as a prognostic factor for outcome in patients with nonspecific low back pain: a systematic review // Spine. - 2014; 14 (5): 816-36.
  7. Boer M., Struys M., Versteegen G. Pain-related catastrophizing in pain patients and people with pain in the general population // Eur. J. Pain. - 2012; 16 (7): 1044-52.
  8. Wieser S., Horisberger B., Schmidhauser S. et al. Cost of low back pain in Switzerland in 2005 // Eur. J. Health Econ. - 2011; 12 (5): 455-67.
  9. Davies C., Nitz A., Mattacola C., Kitzman P. et al. Practice patterns when treating patients with low back pain: a survey of physical therapists // Physiother. Theor. Pract. - 2014; 30 (6): 399-408.
  10. Dagenais S., Caro J., Haldeman S. A systematic review of low back pain cost of illness studies in the United States and internationally // Spine J. - 2008; 8 (1): 8-20.
  11. Deyo R., Weinstein J. Low back pain // N. Engl. J. Med. - 2001; 344: 36370. doi: 10.1056/NEJM200102013440508.
  12. Croft P., Macfarlane G., Papageorgiou A. et al. Outcome of low back pain in general practice: a prospective study // BMJ. - 1998; 316: 1356-9.
  13. Dillingham T. Evaluation and management of low back pain: and overview // State Art Rev. - 1995; 9 (3): 559-74.
  14. Котова О.В., Акарачкова Е.С. Боль в спине: эпидемиология, этиология, лечение // Consilium Medicum. - 2017; 2 (3): 43-7.
  15. Котова О.В., Акарачкова Е.С., Данилов А.Б. Вопросы длительной терапии болевых синдромов // Рус. мед. журн. - 2015; 23 (30): 16-8.
  16. Котова О.В., Акарачкова Е.С. Нежелательные явления нестероидных противовоспалительных препаратов: возможные варианты выхода из ситуации // Consilium Medicum. - 2017; 2 (2): 85-90.
  17. Котова О.В. НПВП: в поисках золотой середины - соотношение безопасность/эффективность // Справ. поликлин. врача. - 2013; 1: 15-8.
  18. Walshe J., Venuto R. Acute oliguric renal failure induced by indomethacin: possible mechanism // Ann. Intern. Med. - 1979; 91: 47-9.
  19. Cannon P. Prostaglandins in congestive heart failure and the effects of nonsteroidal anti-inflammatory drugs // Am. J. Med. - 1986; 81: 123-32.
  20. Bombardier C., Laine L., Reicin А. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis // N. Engl. J. Med. - 2000; 343: 1520-8.
  21. Varga Z., Sabzwari S., Vargova V. Cardiovascular Risk of Nonsteroidal AntiInflammatory Drugs: An Under-Recognized Public Health Issue // Cureus. - 2017; 9 (4): e1144. doi: 10.7759/cureus.1144.
  22. Strom B., Carson J., Schinnar R. et al. Nonsteroidal anti-inflammatory drugs and neutropenia // Arch. Intern. Med. - 1993; 153: 2119-22.
  23. Van Tulder M., Touray T., Furlan A. et al. Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration // Spine. - 2003; 28 (17): 1978-92. doi: 10.1097/01. BRS.0000090503.38830.AD.
  24. Van Tulder M., Becker A., Bekkering T. et al. European guidelines for the management of acute nonspecific low back pain in primary care // Eur. Spine J. -2006; 15 (2): 169-91.
  25. Liu P., Guo W., Zhao X. et al. Intrathecal baclofen, a GABAB receptor agonist, inhibits the expression of p-CREB and NR2B in the spinal dorsal horn in rats with diabetic neuropathic pain // Can. J. Physiol. Pharmacol. - 2014; 92 (8): 655-60.
  26. Huang D., Huang S., Peers C., et al. GABAB receptors inhibit low-voltage activated and high-voltage activated Ca2+ channels in sensory neurons via distinct mechanisms // Biochem. Biophys. Res. Commun. - 2015; 465 (2):188-93.
  27. Narendran R., Duarte R., Valyi A. et al. The needfor and provision of intra the cal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database // BMJ Open. - 2015; 5 (6): e007517.
  28. Dapas F., Hartman S., Martinez L. et al. Baclofen for the treatment of acute low-back syndrome. A double-blind comparison with placebo // Spine (PhilaPa 1976). - 1985; 10 (4): 345-9.
  29. Zaringhalam J., Manaheji H., Rastqar A. et al. Reduction of chronic nonspecific low back pain: a randomised controlled clinical trial on acupuncture and baclofen // Chin. Med. - 2010; 5: 15. doi: 10.1186/1749-8546-5-15.
  30. Deyo R. Comparative validity of the sickness impact profile and shorter scales for functional assessment in low-back pain // Spine. - 1986; 11 (9): 951-4. doi: 10.1097/00007632-198611000-00017.
  31. Weiner D., Perera S., Rudy T. et al. Efficacy of percutaneous electrical nerve stimulation and therapeutic exercise for older adults with chronic low back pain: A randomized controlled trial // Pain. - 2008; 140 (2): 344-57. doi: 10.1016/j.pain.2008.09.005.
  32. Консенсус по ведению пациентов с болью в спине для терапевтов и врачей общей практики поликлиник. Под ред. Н.Н. Яхно, А.Л. Верткина, М.Л. Кукушкина, В.А. Парфенова, А.Е. Каратеева / М., 2017.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies